Interleukin-4 as a therapeutic target.

Interleukin-4 (IL-4) is a pleiotropic cytokine mainly known for its role in type 2 immunity. Therapies antagonizing or blocking IL-4 activity have been developed to counteract diseases such as atopic dermatitis and asthma. In contrast, other disorders experimentally benefit from IL-4-related effects and IL-4 recently demonstrated beneficial activity in experimental stroke, spinal cord injury and the animal model of multiple sclerosis. To exploit IL-4-related activity for therapeutic concepts, current experimental efforts include modifying the pathway without inducing type 2 immune response and targeting of the cytokine to specific tissues. Here, we review different activities of IL-4 as well as therapeutic strategies. Copyright © 2023. Published by Elsevier Inc.

Citation

Yvonne Gärtner, Lynn Bitar, Frauke Zipp, Christina Francisca Vogelaar. Interleukin-4 as a therapeutic target. Pharmacology & therapeutics. 2023 Feb;242:108348

Mesh Tags

Substances

PMID: 36657567

search → result